Is Tepali profitable in 2026?

No public revenue, profit, or customer figures for Tepali exist as of July 22, 2026. The YC launch page and company site disclose no ARR or paying customers, and the company is a 2-person, pre-seed startup with no financial data publicly available.

Could AI replace Tepali's own product?

Tepali's product is itself AI automating front-desk booking and clinical charting for medspas, so it competes directly with incumbents shipping similar AI, like Zenoti's AI Scribe (shipped by April 28, 2026) and Podium's Avery agent (launched January 20, 2026), both from better-funded rivals.

Who is Tepali's biggest competitor?

Podium is Tepali's closest rival, having launched an 'AI Operating System for Aesthetics' powered by its Avery agent on January 20, 2026, roughly six weeks before Tepali's own March 2, 2026 public launch, and updated to Avery 2.0 by March 31, 2026.

Tepali is privately held and founder-owned, co-founded by Vishnu Pathmanaban (ex-Rilla, ex-PJT Partners, NYU Stern 2023) and Chrisvin Jabamani (Carnegie Mellon CS, ex-MealPal, built POS at Dripos), and is part of Y Combinator's Winter 2026 batch as of March 2, 2026.

What does Tepali actually build?

Tepali sells an all-in-one medspa platform bundling POS, EMR/CRM, scheduling, inventory, payroll, and marketing, layered with AI agents for front-desk booking, clinical SOAP-note scribing, and marketing, per its site as of the March 2, 2026 launch.

Has Tepali raised a funding round?

Tepali is backed by Y Combinator as part of its Winter 2026 batch, confirmed via YC's own company page as of March 2, 2026; no independently verified funding amount from a primary source (press release or filing) has been confirmed as of July 22, 2026.

YC Winter 2026 · United States

Tepali

AI-native software system for medspas and aesthetics practices, built by a two-person team.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q2-Q3 2026 · Every call on the record Checkpoint: Tepali's first disclosed paying customer or seed round announcement

The call

Tepali launched two months after Podium shipped a near-identical product, and faces Zenoti's AI features with no disclosed customers of its own yet.

Tepali built software that uses AI to help run beauty and aesthetics businesses, handling tasks like scheduling and customer communication. The problem: Podium shipped almost the same thing two months earlier and already has customers using it, while Zenoti and Boulevard (the big players in this space) added AI features to their existing software that thousands of salons already rely on. Tepali is just two people with no paying customers yet, making a head-to-head fight against companies with money, teams, and existing relationships. The one thing that could matter is if Tepali finds a specific group of salons that the bigger companies are ignoring, or proves that salons will switch from their current software to get something genuinely better.

Why

AI pressure: Podium's Avery agent (AI Operating System for Aesthetics). Podium shipped a full aesthetics AI OS with the Avery agent in January 2026, two months before Tepali's public launch. Could AI do the core job? Yes, likely.

Bigger players: Zenoti. Zenoti, already running tens of thousands of locations, shipped an AI Scribe for clinical charting in April 2026. Could a giant copy it? Yes, easily.

What protects it. Founders' prior vertical software experience at Rilla and Dripos, which gives them a faster read on medspa workflows than a generic build.

What would change this call

Tepali discloses its first paying customer or case study within 12 months. Would show it can convert launch buzz into real switching from incumbents like Zenoti or Boulevard.
Podium ships Avery 3.0 or expands into payroll/inventory modules. Would show incumbent is closing the full-OS gap Tepali is trying to occupy.
Tepali announces a seed round or team expansion beyond 2 founders. Would show it has resources to compete on distribution and product breadth.

Key numbers

Podium launched aesthetics AI OS with Avery (2026-01-20)
Zenoti runs tens of thousands of locations (2026-04-04)
Tepali team: 2 co-founders, no open roles listed (2026-07-22)

Named risks

No disclosed paying customers, revenue, or case studies as of July 22, 2026. Severity: high
Two-person founding team with no hiring activity, limiting execution capacity. Severity: high
Podium and Zenoti shipped near-identical AI OS and AI Scribe features before or shortly after Tepali's launch. Severity: high
Ten-plus entrenched incumbents (Boulevard, Zenoti, Pabau, AestheticsPro, etc.) already hold system-of-record lock-in. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Podium	losing to	Podium launched near-identical AI OS for Aesthetics on Jan 20, 2026, ~6 weeks before Tepali's Mar 2, 2026 launch
Zenoti	losing to	Zenoti serves tens of thousands of locations and shipped AI Scribe by Apr 28, 2026, versus Tepali's 2-person, no-customer stage
Boulevard	contesting	Established boutique medspa booking platform named as direct peer in Apr 4, 2026 comparison
Aesthetic Record	contesting	Existing EMR/practice management platform for solo injectors, named peer as of Apr 4, 2026

Questions people ask

Is Tepali profitable in 2026?: No public revenue, profit, or customer figures for Tepali exist as of July 22, 2026. The YC launch page and company site disclose no ARR or paying customers, and the company is a 2-person, pre-seed startup with no financial data publicly available.
Could AI replace Tepali's own product?: Tepali's product is itself AI automating front-desk booking and clinical charting for medspas, so it competes directly with incumbents shipping similar AI, like Zenoti's AI Scribe (shipped by April 28, 2026) and Podium's Avery agent (launched January 20, 2026), both from better-funded rivals.
Who is Tepali's biggest competitor?: Podium is Tepali's closest rival, having launched an 'AI Operating System for Aesthetics' powered by its Avery agent on January 20, 2026, roughly six weeks before Tepali's own March 2, 2026 public launch, and updated to Avery 2.0 by March 31, 2026.
Who owns Tepali?: Tepali is privately held and founder-owned, co-founded by Vishnu Pathmanaban (ex-Rilla, ex-PJT Partners, NYU Stern 2023) and Chrisvin Jabamani (Carnegie Mellon CS, ex-MealPal, built POS at Dripos), and is part of Y Combinator's Winter 2026 batch as of March 2, 2026.
What does Tepali actually build?: Tepali sells an all-in-one medspa platform bundling POS, EMR/CRM, scheduling, inventory, payroll, and marketing, layered with AI agents for front-desk booking, clinical SOAP-note scribing, and marketing, per its site as of the March 2, 2026 launch.
Has Tepali raised a funding round?: Tepali is backed by Y Combinator as part of its Winter 2026 batch, confirmed via YC's own company page as of March 2, 2026; no independently verified funding amount from a primary source (press release or filing) has been confirmed as of July 22, 2026.

Timeline

2026-07-22YC jobs page shows Tepali still at 2 co-founders, no open roles, no disclosed customers
2026-04-28Zenoti ships AI Scribe for clinical charting, vendor claims ~60 min/day saved
2026-04-04Phorest comparison lists Zenoti at tens of thousands of locations among 10+ medspa rivals
2026-03-31Podium updates AI Operating System for Aesthetics to Avery 2.0
2026-03-12YC W26 batch Demo Day investor activity underway
2026-03-02Tepali publicly launches via YC, shifts positioning from Agentic OS to AI-native OS for aesthetics
2026-01-20Podium launches AI Operating System for Aesthetics powered by Avery, ahead of Tepali

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

CellType OctaPulse The Token Company